Dalrada Financial Corporation has announced that its healthcare subsidiary, Genefic, Inc., has acquired IV Services, LLC, an established infusion pharmacy business. This strategic move enables Genefic to expand its operational footprint and increase revenue through new product offerings. The acquisition is non-dilutive to Dalrada shareholders and places Genefic in the growing $42 billion global infusion pharmacy market, projected to reach $70 billion by 2030. The move adds pharmacy licenses in Louisiana and Mississippi, complementing Genefic’s existing licenses and expanding its market reach.

Healthcare, Pharmaceuticals, Financial,United States